Results 91 to 100 of about 35,256 (161)

Effectiveness and Safety of Polatuzumab Vedotin Plus an Anti-CD20 Monoclonal Antibody (Rituximab or Obinutuzumab) and Zanubrutinib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma. [PDF]

Cancer Med
Zhang Y, Ren Y, Zhuang J, Yuan L, Wang Z, Zhang X, Wang W, Cheng Z, Cheng L, Li J, Liu P.   +10 more
europepmc   +1 more source

Treatment outcomes of BTK inhibitors and venetoclax with or without anti-CD20 monoclonal antibody in relapsed or refractory mantle cell lymphoma. [PDF]

Ann Hematol
Yang P, Li CY, Liu SZ, Wang J, Chen YT, Zhang WL, Jing HM.   +6 more
europepmc   +1 more source

A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis. [PDF]

Mult Scler, 2021
Fox E, Lovett-Racke AE, Gormley M, Liu Y, Petracca M, Cocozza S, Shubin R, Wray S, Weiss MS, Bosco JA, Power SA, Mok K, Inglese M.   +12 more
europepmc   +1 more source

Case report: The case report of ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of KLHL11 encephalitis. [PDF]

Front Immunol
Deng M, Zeng F, Kong Z, Li T.
europepmc   +1 more source

Echovirus serotype 11 induced sepsis in a young female patient with multiple sclerosis treated with anti-CD20 monoclonal antibody ocrelizumab. [PDF]

Infection
Starosta AD, Ehler J, Löffler B, Tannapfel A, Zipprich A, Reuken PA, Stallmach A.   +6 more
europepmc   +1 more source

First-in-Human Study of BAT4406F, an ADCC-Enhanced Fully Humanized Anti-CD20 Monoclonal Antibody in Patients With Neuromyelitis Optica Spectrum Disorders. [PDF]

CNS Neurosci Ther
Yu H, Chen Y, Qi Y, Yang H, Cao G, Yang W, Li S, Yang X, Wang H, Zhang J, Chen X.   +10 more
europepmc   +1 more source

Safety and biologic activity of a canine anti-CD20 monoclonal antibody in dogs with diffuse large B-cell lymphoma. [PDF]

J Vet Intern Med
McLinden GP, Avery AC, Gardner HL, Hughes K, Rodday AM, Liang K, London CA.   +6 more
europepmc   +1 more source

Establishment of C₂₀Mab-11, a novel anti-CD20 monoclonal antibody, for the detection of B cells. [PDF]

Oncol Lett, 2020
Furusawa Y, Kaneko MK, Kato Y.
europepmc   +1 more source

A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial. [PDF]

BMC Cancer, 2021
Grunenberg A, Kaiser LM, Woelfle S, Schmelzle B, Viardot A, Möller P, Barth TFE, Muche R, Dreyhaupt J, Raderer M, Kiesewetter B, Buske C.   +11 more
europepmc   +1 more source

Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy. [PDF]

Eur J Clin Microbiol Infect Dis
Feuth E, Nieminen V, Palomäki A, Ranti J, Sucksdorff M, Finnilä T, Oksi J, Vuorinen T, Feuth T.   +8 more
europepmc   +1 more source